M&A Deal Summary

Octapharma AG Acquires Glycotope Biotechnology - Recombinant Technology

On October 8, 2015, Octapharma AG acquired medical products company Glycotope Biotechnology - Recombinant Technology from Glycotope Biotechnology for 80M EUR

Acquisition Highlights
  • This is Octapharma AG’s 1st transaction in the Medical Products sector.
  • This is Octapharma AG’s 0th largest (disclosed) transaction.
  • This is Octapharma AG’s 1st transaction in the United States.

M&A Deal Summary
Date 2015-10-08
Target Glycotope Biotechnology - Recombinant Technology
Sector Medical Products
Buyer(s) Octapharma AG
Sellers(s) Glycotope Biotechnology
Deal Type Divestiture
Deal Value 80M EUR

Target

Glycotope Biotechnology - Recombinant Technology

United States
Glycotope Biotechnology - Recombinant Technology is a developer of biotechnology products and services.

Search 199,712 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Octapharma AG

Lachen, Switzerland
Category Company
Founded 1983
Sector Life Science
Employees5,683
DESCRIPTION

Octapharma AG is a biotechnology company.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 1 of 1
Year (2015) 1 of 1

Seller(S) 1

SELLER

Glycotope Biotechnology

Heidelberg, Germany
Category Company
Founded 2008
Sector Life Science
DESCRIPTION

Glycotope Biotechnology GmbH is a biotechnology company.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 1 of 1
Year (2015) 1 of 1
Mergr

Product

Company

Legal